Skip to main content
. Author manuscript; available in PMC: 2017 Mar 10.
Published in final edited form as: Antivir Ther. 2016 May 11;22(1):13–20. doi: 10.3851/IMP3055

Table 3. HBV drug resistance pattern among 21 HIV-HBV co-infected patients.

Pattern Number Percent
rtL180M, rtM204V 10 47.6%
rtV173L, rtL180M, rtM204V 5 23.8%
rtV173L, rtL180M, rtM204I 1 4.76%
rtL80I, rtL180M, rtM204V 2 9.52%
rtL80I, rtM204I 1 4.76%
rtL180M, rtM204I 1 4.76%
rtL180M 1 4.76%